These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 33587255)
41. Failure of radioiodine to induce thyroid cancer in the rat. FIELD JB; McCAMMON CJ; VALENTINE RJ; BERNICK S; ORR C; STARR P Cancer Res; 1959 Sep; 19():870-3. PubMed ID: 13822678 [No Abstract] [Full Text] [Related]
42. [Lithium as an adjuvant in the radioiodine therapy of thyroid cancer]. Schraube P; Kimmig B; zum Winkel K Nuklearmedizin; 1984 Jun; 23(3):151-4. PubMed ID: 6435095 [TBL] [Abstract][Full Text] [Related]
43. Limitations and indications in the treatment of cancer of the thyroid with radioactive iodine. RAWSON RW; RALL JE; PEACOCK W J Clin Endocrinol Metab; 1951 Oct; 11(10):1128-42. PubMed ID: 14873783 [No Abstract] [Full Text] [Related]
44. Radioiodine imaging and treatment in thyroid disorders. Griggs WS; Divgi C Neuroimaging Clin N Am; 2008 Aug; 18(3):505-15, viii. PubMed ID: 18656031 [TBL] [Abstract][Full Text] [Related]
46. Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysis. Shen CT; Qiu ZL; Luo QY Endocr Relat Cancer; 2014 Apr; 21(2):253-61. PubMed ID: 24302666 [TBL] [Abstract][Full Text] [Related]
47. Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone. Berg G; Lindstedt G; Suurküla M; Jansson S J Endocrinol Invest; 2002 Jan; 25(1):44-52. PubMed ID: 11883865 [TBL] [Abstract][Full Text] [Related]
48. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499 [TBL] [Abstract][Full Text] [Related]
49. The treatment of thyroid carcinoma with radioactive iodine. Beierwaltes WH Semin Nucl Med; 1978 Jan; 8(1):79-94. PubMed ID: 345448 [TBL] [Abstract][Full Text] [Related]
50. A phase II study using retinoids as redifferentiation agents to increase iodine uptake in metastatic thyroid cancer. Short SC; Suovuori A; Cook G; Vivian G; Harmer C Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):569-74. PubMed ID: 15630851 [TBL] [Abstract][Full Text] [Related]
51. Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer. Padma S; Sundaram PS J Cancer Res Ther; 2016; 12(3):1109-1113. PubMed ID: 28054519 [TBL] [Abstract][Full Text] [Related]
52. Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer. Choi YJ; Lee JE; Ji HD; Lee BR; Lee SB; Kim KS; Lee IK; Chin J; Cho SJ; Lee J; Lee SW; Ha JH; Jeon YH Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499100 [TBL] [Abstract][Full Text] [Related]
60. Problems of thyroid cancer and its treatment by radioiodine. HALNAN KE Nucl Med (Stuttg); 1959 Mar; 1():1-26. PubMed ID: 14399141 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]